The adherence and persistence to oral bisphosphonate therapies is poor in many cases. This bears importance because the treatment for osteoporosis is only effective if the Medication Possession Ratio (MPR- a marker for compliance) is greater than 80%. There are several causes for poor adherence; prominent among them being a lack of patient understanding about the significance of osteoporosis and the adverse consequences associated with it. This presentation discusses the causes of poor adherence; presents data on the adherence and persistence of osteoporosis treatments in context with other disease areas; and reviews recent evidence on interventions to increasing compliance. The utility of using intravenous bisphosphonates and subcutaneous treatments are also discussed.
  • 1602755220-55bbcbe73ae6a772
    Professor Tahir Masud
    Consultant Physician in Geriatric Medicine, Nottingham University Hospitals NHS Trust

    Professor Masud is the current President of the British Geriatrics Society. He trained at University of Oxford and St Bartholomew’s Hospital, London. After postgraduate training in London and Newcastle-Upon-Tyne and a research fellow post in St Thomas’ Hospital, London he took up the position of Consultant Physician in General and Geriatric Medicine at Nottingham in 1994. He has a research and clinical interest in osteoporosis, falls and syncope and has published widely in these areas. He heads the Clinical Gerontology Research Unit at Nottingham University Hospitals NHS Trust. He has previously been a scientific advisor to the National Osteoporosis Society and is the main organiser of the annual International Conference on Falls and Postural Stability. He has also served as the Clinical Sub-Dean at the University of Nottingham Medical School. He also has honorary/visiting professorships at the Universities of Nottingham, Derby and Southern Denmark. He is the former President of the European Union of Medical Specialists-Geriatric Medicine Section.